TransMedics Group (TMDX)
(Real Time Quote from BATS)
$141.09 USD
-4.90 (-3.36%)
Updated Jul 26, 2024 12:40 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Price, Consensus and EPS Surprise
TMDX 141.09 -4.90(-3.36%)
Will TMDX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TMDX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TMDX
Is Hims & Hers Health (HIMS) Stock Outpacing Its Medical Peers This Year?
Here's How STERIS (STE) is Placed Ahead of Q1 Earnings
TMDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings
TransMedics (TMDX) Moves to Buy: Rationale Behind the Upgrade
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
Other News for TMDX
Commit To Buy TransMedics Group At $75, Earn 14.7% Using Options
$1000 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
Healthcare 2024 Second Half Outlook
TMDX Crosses Above Average Analyst Target
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)